Metagenomi Therapeutics (MGX) Q3 2026 Earnings

19AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Next
-0.62
-0.59
-0.57
-0.54

Details

Expected EPS
-0.576342
Actual EPS
N/A
Surprise EPS
0.58
Surprise Percent
+100%

Description

Metagenomi Therapeutics (MGX) will report earnings of for Q3 2026 on August 19, 2026.

0 Comments

Share your thoughts